146 related articles for article (PubMed ID: 3908733)
1. [Therapeutic effects of micronomicin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y
Jpn J Antibiot; 1985 Aug; 38(8):2129-38. PubMed ID: 3908733
[TBL] [Abstract][Full Text] [Related]
2. [Effects of cefoxitin in the treatment of severe infections in patients with hematopoietic disorders].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Tsubakio T; Kawagoe H; Shinohara Y; Nasu T
Jpn J Antibiot; 1982 May; 35(5):1212-22. PubMed ID: 6752459
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
Hamazaki H; Horiuchi A; Hasegawa H; Masaoka T; Kitani T; Kanayama Y; Sugiyama H; Tatsumi N; Kageyama T; Uchino H
Jpn J Antibiot; 1994 Jun; 47(6):763-70. PubMed ID: 8072185
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effects of cefclidin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Tatsumi N; Im T; Furukawa Y; Sannomiya Y; Inoue K; Kageyama T; Ohyabu H; Akasaka K; Nasu K; Yonezawa T
Jpn J Antibiot; 1992 May; 45(5):512-22. PubMed ID: 1512937
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
Yamane T; Nakao Y; Yasui Y; Ota K; Ohira H; Inoue T; Furukawa Y; Hiyoshi M; Sasaki A; Kishida T
Jpn J Antibiot; 1990 Nov; 43(11):1843-9. PubMed ID: 2287053
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
Hirayama F; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Okamoto Y; Yonezawa T
Jpn J Antibiot; 1985 Sep; 38(9):2402-12. PubMed ID: 4079014
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
Kageyama T; Ohyabu H; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Yonezawa T
Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
[TBL] [Abstract][Full Text] [Related]
10. [Fundamental and clinical studies of intravenous drip infusion of micronomicin in respiratory tract infection].
Oshitani H; Takeda H; Nihei T; Kobayashi H
Jpn J Antibiot; 1984 Sep; 37(9):1603-6. PubMed ID: 6512979
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effect of cefotaxime against severe infections in patients with hematopoietic diseases].
Tsubakio T; Kanayama Y; Yonezawa T; Kitani T; Taniguchi N; Masaoka T; Shibata H; Horiuchi A; Hasegawa H; Kawagoe H
Jpn J Antibiot; 1983 Oct; 36(10):2893-900. PubMed ID: 6325748
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies of intravenous drip infusion of micronomicin. Internal field infections].
Ikemoto H
Jpn J Antibiot; 1984 Jan; 37(1):111-21. PubMed ID: 6727032
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic trials with tobramycin.
Valdivieso M; Horikoshi N; Rodriguez V; Bodey GP
Am J Med Sci; 1974 Sep; 268(3):149-56. PubMed ID: 4613176
[No Abstract] [Full Text] [Related]
14. [Clinical studies on intravenous drip-infusion of micronomicin for complicated urinary tract infections].
Kumon H; Ohmori H
Jpn J Antibiot; 1984 Aug; 37(8):1445-52. PubMed ID: 6502931
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on micronomicin in the field of internal medicine].
Komatsu Y; Kakizaki R; Tsushima K; Sakata Y
Jpn J Antibiot; 1983 Mar; 36(3):529-36. PubMed ID: 6876362
[TBL] [Abstract][Full Text] [Related]
16. [Septicemia associated with hematopoietic disorders and its features according to respective primary disorders].
Yokota T; Teshima H; Okajima Y; Tsuboi A; Oji Y; Karasuno T; Hiraoka A; Masaoka T
Kansenshogaku Zasshi; 1996 Feb; 70(2):108-15. PubMed ID: 8851382
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Ito A; Maruta I; Ogawa K; Asada H; Matsuzaki M
Jpn J Antibiot; 1985 Aug; 38(8):2108-18. PubMed ID: 4079002
[TBL] [Abstract][Full Text] [Related]
18. [Clinical investigation of cefotiam in combination with aminoglycoside or (and) penicillin against complicated infections with hematopoietic disorders].
Uno N; Minami N; Tanaka I; Katayama N; Kamio N; Kataoka Y; Ota C; Koh T; Ono T; Kageyama S
Jpn J Antibiot; 1984 May; 37(5):807-16. PubMed ID: 6090722
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of astromicin by intravenous drip infusion. Report I. Bacterial infections in the field of internal medicine].
Hara K; Saito A; Shigeno Y; Kohno S; Ishikawa K; Kato Y; Kikuchi K; Yamamoto A; Hiraga Y; Oizumi K
Jpn J Antibiot; 1986 Nov; 39(11):2926-37. PubMed ID: 3820571
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effects of micronomicin on experimental infections in mice by intravenous administration].
Sato K; Yamashita K; Okachi R
Jpn J Antibiot; 1983 Nov; 36(11):3277-82. PubMed ID: 6371292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
